AMERICAN SHARED HOSPITAL SERVICES (AMS) Gross Margin
- Gross margin · 12 months: Value 17.14%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 17.14% | Gross profit / revenue. Period ending 2026-06-30. $5.21M ÷ $30.41M × 100 ≈ 17.14% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 5.21M USD | Gross Profit |
| Revenue | 30.41M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $5.21M | $30.41M | (m) | 17.14% |
| 2026-03-31 | $5.41M | $29.05M | (m) | 18.62% |
| 2025-12-31 | $5.06M | $28.08M | (m) | 18.03% |
| 2025-09-30 | $7.36M | $29.42M | (m) | 25.02% |
| 2025-06-30 | $7.15M | $29.25M | (m) | 24.43% |
| 2025-03-31 | $7.98M | $29.24M | (m) | 27.31% |
| 2024-12-31 | $9.19M | $28.34M | (m) | 32.41% |
| 2024-09-30 | $8.80M | $24.97M | (m) | 35.23% |
| 2024-06-30 | $9.53M | $23.10M | (m) | 41.24% |
| 2024-03-31 | $9.58M | $21.62M | (m) | 44.31% |
| 2023-12-31 | $9.34M | $21.32M | (m) | 43.82% |
| 2023-09-30 | $8.80M | $20.66M | (m) | 42.58% |
| 2023-06-30 | $8.65M | $20.36M | (m) | 42.50% |
| 2023-03-31 | $8.22M | $19.82M | (m) | 41.48% |
| 2022-12-31 | $8.38M | $19.75M | (m) | 42.45% |
| 2022-09-30 | $8.33M | $19.40M | (m) | 42.94% |
| 2022-06-30 | $7.84M | $18.67M | (m) | 41.99% |
| 2022-03-31 | $7.36M | $18.11M | (m) | 40.63% |
| 2021-12-31 | $6.73M | $17.63M | (m) | 38.16% |
| 2021-09-30 | $5.54M | $17.55M | (m) | 31.54% |
| 2021-06-30 | $5.21M | $18.12M | (m) | 28.73% |
| 2021-03-31 | $4.51M | $17.63M | (m) | 25.55% |
| 2020-12-31 | $4.47M | $17.84M | (m) | 25.04% |
| 2020-09-30 | $4.88M | $18.02M | (m) | 27.09% |
| 2020-06-30 | $5.55M | $18.65M | (m) | 29.79% |
| 2020-03-31 | $6.38M | $19.85M | (m) | 32.12% |
| 2019-12-31 | $6.92M | $20.61M | (m) | 33.58% |
| 2019-09-30 | $7.04M | $20.59M | (m) | 34.21% |
| 2019-06-30 | $6.87M | $19.76M | (m) | 34.75% |
| 2019-03-31 | $7.22M | $19.73M | (m) | 36.58% |
| 2018-12-31 | $7.49M | $19.71M | (m) | 37.97% |
| 2018-09-30 | $8.11M | (m) | (m) | (m) |
| 2018-06-30 | $8.35M | (m) | (m) | (m) |
| 2018-03-31 | $8.52M | (m) | (m) | (m) |
| 2017-12-31 | $8.66M | (m) | (m) | (m) |
| 2017-09-30 | $9.31M | (m) | (m) | (m) |
| 2017-06-30 | $9.82M | (m) | (m) | (m) |
| 2017-03-31 | $9.41M | (m) | (m) | (m) |
| 2016-12-31 | $8.79M | (m) | (m) | (m) |
| 2016-09-30 | $7.83M | (m) | (m) | (m) |
| 2016-06-30 | $6.89M | (m) | (m) | (m) |
| 2016-03-31 | $6.85M | (m) | (m) | (m) |
| 2015-12-31 | $6.71M | (m) | (m) | (m) |
| 2015-09-30 | $6.39M | (m) | (m) | (m) |
| 2015-06-30 | $6.54M | (m) | (m) | (m) |
| 2015-03-31 | $5.59M | (m) | (m) | (m) |
| 2014-12-31 | $5.28M | (m) | (m) | (m) |
| 2014-09-30 | $5.09M | (m) | (m) | (m) |
| 2014-06-30 | $5.07M | (m) | (m) | (m) |
| 2014-03-31 | $6.12M | (m) | (m) | (m) |
| 2013-12-31 | $6.94M | (m) | (m) | (m) |
| 2013-09-30 | $7.12M | (m) | (m) | (m) |
| 2013-06-30 | $7.23M | (m) | (m) | (m) |
| 2013-03-31 | $7.21M | (m) | (m) | (m) |
| 2012-12-31 | $6.93M | (m) | (m) | (m) |
| 2012-09-30 | $7.18M | (m) | (m) | (m) |
| 2012-06-30 | $7.95M | (m) | (m) | (m) |
| 2012-03-31 | $7.91M | (m) | (m) | (m) |
| 2011-12-31 | $8.00M | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $7.21M | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $6.99M | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |